These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23171000)

  • 1. Automatic design of decision-tree induction algorithms tailored to flexible-receptor docking data.
    Barros RC; Winck AT; Machado KS; Basgalupp MP; de Carvalho AC; Ruiz DD; de Souza ON
    BMC Bioinformatics; 2012 Nov; 13():310. PubMed ID: 23171000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).
    Khan AM; Shawon J; Halim MA
    J Mol Graph Model; 2017 Oct; 77():386-398. PubMed ID: 28957755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining flexible-receptor docking experiments to select promising protein receptor snapshots.
    Machado KS; Winck AT; Ruiz DD; de Souza ON
    BMC Genomics; 2010 Dec; 11 Suppl 5(Suppl 5):S6. PubMed ID: 21210972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations.
    Cohen EM; Machado KS; Cohen M; de Souza ON
    BMC Genomics; 2011 Dec; 12 Suppl 4(Suppl 4):S7. PubMed ID: 22369213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.
    Tripathi A; Wadia N; Bindal D; Jana T
    Indian J Biochem Biophys; 2012 Dec; 49(6):435-41. PubMed ID: 23350278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-Based Design of
    Sabbah M; Mendes V; Vistal RG; Dias DMG; Záhorszká M; Mikušová K; Korduláková J; Coyne AG; Blundell TL; Abell C
    J Med Chem; 2020 May; 63(9):4749-4761. PubMed ID: 32240584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
    Minovski N; Perdih A; Novic M; Solmajer T
    J Comput Chem; 2013 Apr; 34(9):790-801. PubMed ID: 23280926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features.
    De Paris R; Quevedo CV; Ruiz DD; Norberto de Souza O
    PLoS One; 2015; 10(7):e0133172. PubMed ID: 26218832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.
    Merget B; Sotriffer CA
    PLoS One; 2015; 10(5):e0127009. PubMed ID: 25996598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FReDoWS: a method to automate molecular docking simulations with explicit receptor flexibility and snapshots selection.
    Machado KS; Schroeder EK; Ruiz DD; Cohen EM; de Souza ON
    BMC Genomics; 2011 Dec; 12 Suppl 4(Suppl 4):S6. PubMed ID: 22369186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel InhA reductase inhibitors: application of pharmacophore- and shape-based screening approach.
    Kumar UC; Bvs SK; Mahmood S; D S; Kumar-Sahu P; Pulakanam S; Ballell L; Alvarez-Gomez D; Malik S; Jarp S
    Future Med Chem; 2013 Mar; 5(3):249-59. PubMed ID: 23464516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.
    da Costa AL; Pauli I; Dorn M; Schroeder EK; Zhan CG; de Souza ON
    J Mol Model; 2012 May; 18(5):1779-90. PubMed ID: 21833828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic design of decision-tree algorithms with evolutionary algorithms.
    Barros RC; Basgalupp MP; de Carvalho AC; Freitas AA
    Evol Comput; 2013; 21(4):659-84. PubMed ID: 23339552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach.
    Pauli I; dos Santos RN; Rostirolla DC; Martinelli LK; Ducati RG; Timmers LF; Basso LA; Santos DS; Guido RV; Andricopulo AD; Norberto de Souza O
    J Chem Inf Model; 2013 Sep; 53(9):2390-401. PubMed ID: 23889525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen.
    Scheich C; Szabadka Z; Vértessy B; Pütter V; Grolmusz V; Schade M
    PLoS One; 2011; 6(12):e28428. PubMed ID: 22164290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore mapping, molecular docking, chemical synthesis of some novel pyrrolyl benzamide derivatives and evaluation of their inhibitory activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Joshi SD; Dixit SR; Basha J; Kulkarni VH; Aminabhavi TM; Nadagouda MN; Lherbet C
    Bioorg Chem; 2018 Dec; 81():440-453. PubMed ID: 30223149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA.
    Kumar V; Sobhia ME
    PLoS One; 2015; 10(12):e0144635. PubMed ID: 26658674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.